MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference
VALENCIA, Calif., Jan. 8, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation
(Nasdaq:MNKD), focused on discovering, developing and commercializing
treatments for diabetes, announced today that it will present at the J.P.
Morgan 2014 Healthcare Conference on Wednesday, January 15, 2014 at 7:30 AM
(PST) at Westin St. Francis Hotel in San Francisco, California.
Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical
trials. MannKind maintains a website at www.mannkindcorp.com to which MannKind
regularly posts copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind website to
e-mail alerts that are sent automatically when MannKind issues press releases,
files its reports with the Securities and Exchange Commission or posts certain
other information to the website.
CONTACT: MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
MannKind Corporation Logo
Press spacebar to pause and continue. Press esc to stop.